Title | Description |
|---|---|
| Trial ID | KF5503/44 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3b |
| Brief title | Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics |
| Indication | Chronic Pain, Low back pain, Neuropathic pain, Nociceptive Pain |
| UTN | |
| CTG ID | NCT00983385 |
| CTIS ID (former EudraCT) | 2009-010427-12 |
| Trial status | Completed |
| FPI | September 30, 2009 |
| LPO | July 6, 2010 |
| Countries | Austria, Croatia, France, Germany, Italy, Poland, Spain, Switzerland, United Kingdom |
| Gender | All |
| Age | >= 18 years of age |
| Results | Yes |
| Pubmed | 22443293 |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.